Loading...

Sawai Group Holdings Co., Ltd.

SWGHFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$11.52
$0.00(0.00%)

Sawai Group Holdings Co., Ltd. (SWGHF) Company Profile & Overview

Explore Sawai Group Holdings Co., Ltd.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Sawai Group Holdings Co., Ltd. (SWGHF) Company Profile & Overview

Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research, development, manufacturing, and marketing of generic pharmaceutical products primarily in Japan and the United States. The company offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, granules, capsules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms in the therapeutic areas of cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, anti-cancer, chemotherapeutic agents, etc., as well as vitamin preparations. It sells its generic drugs to distributors, wholesalers, and retailers in Japan and the United States. The company was founded in 1929 and is headquartered in Osaka, Japan.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMitsuo Sawai

Contact Information

81 6 6105 5818
5-2-30, Miyahara, Osaka, 532-0003

Company Facts

3,482 Employees
IPO DateNov 9, 2021
CountryJP
Actively Trading

Frequently Asked Questions

;